Ron Cohen
2009
In 2009, Ron Cohen earned a total compensation of $2.1M as President and Chief Executive Officer at Acorda Therapeutics, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $280,888 |
|---|---|
| Option Awards | $823,313 |
| Salary | $483,717 |
| Stock Awards | $514,750 |
| Other | $7,350 |
| Total | $2,110,018 |
Cohen received $823.3K in option awards, accounting for 39% of the total pay in 2009.
Cohen also received $280.9K in bonus, $483.7K in salary, $514.8K in stock awards and $7.4K in other compensation.
Rankings
In 2009, Ron Cohen's compensation ranked 2,250th out of 9,885 executives tracked by ExecPay. In other words, Cohen earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,250 out of 9,885 | 77th |
Division Manufacturing | 792 out of 3,690 | 79th |
Major group Chemicals And Allied Products | 153 out of 866 | 82nd |
Industry group Drugs | 89 out of 638 | 86th |
Industry Biological Products, Except Diagnostic Substances | 15 out of 133 | 89th |
Source: SEC filing on April 26, 2012.
Cohen's colleagues
We found four more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2009.
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019